Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:CLGNNASDAQ:COCHNASDAQ:LYRANASDAQ:MDAI On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCLGNCollPlant Biotechnologies$1.38-2.5%$1.89$1.31▼$5.48$17.60M1.3334,878 shs17,946 shsCOCHEnvoy Medical$1.58+5.4%$1.51$1.21▼$3.99$33.48M2.2280,631 shs9,689 shsLYRALyra Therapeutics$9.02-3.2%$9.50$3.81▼$37.50$11.93M0.24192,535 shs43,492 shsMDAISpectral AI$2.71+6.9%$1.75$0.82▼$3.25$67.85M0.9874,662 shs718,805 shs2025 Gold Forecast: A Perfect Storm for DemandUnlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCLGNCollPlant Biotechnologies0.00%+0.28%-37.10%-42.22%-72.32%COCHEnvoy Medical0.00%+3.33%+9.79%+14.98%-32.44%LYRALyra Therapeutics0.00%-1.04%-60.50%+49.50%-35.61%MDAISpectral AI0.00%+27.59%+57.27%+123.55%+44.65%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationCLGNCollPlant Biotechnologies2.5197 of 5 stars3.75.00.00.00.60.00.6COCHEnvoy Medical2.8231 of 5 stars3.52.00.00.03.03.30.0LYRALyra Therapeutics2.2914 of 5 stars3.22.00.00.02.61.70.6MDAISpectral AI3.0193 of 5 stars3.72.00.00.03.13.30.0Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCLGNCollPlant Biotechnologies 3.33Buy$11.50730.98% UpsideCOCHEnvoy Medical 3.00Buy$9.25485.07% UpsideLYRALyra Therapeutics 2.33Hold$100.001,009.26% UpsideMDAISpectral AI 3.33Buy$4.7575.60% UpsideCurrent Analyst Ratings BreakdownLatest LYRA, CLGN, MDAI, and COCH Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/28/2025CLGNCollPlant BiotechnologiesD. Boral CapitalSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$14.00 ➝ $12.005/27/2025COCHEnvoy MedicalAscendiant Capital MarketsSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$9.25 ➝ $9.504/21/2025COCHEnvoy MedicalAscendiant Capital MarketsSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$9.00 ➝ $9.25(Data available from 7/5/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCLGNCollPlant Biotechnologies$510K34.52N/AN/A$1.18 per share1.17COCHEnvoy Medical$220K153.29N/AN/A($0.88) per share-1.80LYRALyra Therapeutics$1.53M7.84N/AN/A$8.86 per share1.02MDAISpectral AI$29.58M2.32N/AN/A($0.32) per share-8.45Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCLGNCollPlant Biotechnologies-$16.61M-$1.22N/AN/AN/A-560.92%-87.33%-65.31%7/16/2025 (Estimated)COCHEnvoy Medical-$20.80M-$1.38N/AN/AN/A-10,656.13%N/A-237.44%8/11/2025 (Estimated)LYRALyra Therapeutics-$93.43M-$60.50N/AN/AN/A-6,711.39%-295.52%-66.95%8/13/2025 (Estimated)MDAISpectral AI-$15.31M-$0.54N/AN/AN/A-30.75%N/A-11.37%N/ALatest LYRA, CLGN, MDAI, and COCH EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails6/4/2025Q1 2025CLGNCollPlant Biotechnologies-$0.37-$0.13+$0.24-$0.13$9.76 million$2.06 million5/6/2025Q1 2025LYRALyra Therapeutics-$7.50-$6.00+$1.50-$0.13$0.16 million$0.18 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthCLGNCollPlant BiotechnologiesN/AN/AN/AN/AN/ACOCHEnvoy MedicalN/AN/AN/AN/AN/ALYRALyra TherapeuticsN/AN/AN/AN/AN/AMDAISpectral AIN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioCLGNCollPlant BiotechnologiesN/A4.484.23COCHEnvoy MedicalN/A1.090.88LYRALyra TherapeuticsN/A2.962.96MDAISpectral AIN/A1.411.37Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCLGNCollPlant Biotechnologies21.69%COCHEnvoy Medical8.59%LYRALyra Therapeutics95.62%MDAISpectral AI67.08%Insider OwnershipCompanyInsider OwnershipCLGNCollPlant Biotechnologies9.60%COCHEnvoy Medical58.90%LYRALyra Therapeutics3.25%MDAISpectral AI30.70%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableCLGNCollPlant Biotechnologies7012.72 million11.50 millionOptionableCOCHEnvoy Medical3421.33 million8.77 millionNot OptionableLYRALyra Therapeutics501.33 million1.28 millionOptionableMDAISpectral AI8325.32 million17.55 millionNot OptionableLYRA, CLGN, MDAI, and COCH HeadlinesRecent News About These CompaniesNorthland Capmk Lifts Earnings Estimates for Spectral AI1 hour ago | americanbankingnews.comSpectral AI FY2025 EPS Forecast Raised by Northland CapmkJuly 3 at 7:28 AM | marketbeat.comAnalyzing Disaboom (OTCMKTS:MEDH) and Spectral AI (NASDAQ:MDAI)July 1, 2025 | americanbankingnews.comSpectral AI, Inc.: Spectral AI Announces Submission to FDA of its DeepView SystemJune 30, 2025 | finanznachrichten.deSpectral AI Announces Submission to FDA of its DeepView® SystemJune 30, 2025 | globenewswire.comSpectral AI, Inc. (MDAI) - Yahoo FinanceJune 25, 2025 | finance.yahoo.comA Look At The Intrinsic Value Of Spectral AI, Inc. (NASDAQ:MDAI)June 22, 2025 | finance.yahoo.comSpectral Ai Inc Share Chat (MDAI.US)June 11, 2025 | lse.co.ukDeepView® System highlighted at the annual British Burn Association conferenceJune 10, 2025 | globenewswire.comSpectral AI Announces Appointment of Stanley Micek as Chief Operating OfficerMay 30, 2025 | globenewswire.comSpectral AI Announces Voting Results from 2025 Annual Meeting of StockholdersMay 29, 2025 | globenewswire.comDeepView® System Achieves 95.3% Accuracy Evaluation as Published in Burns JournalMay 27, 2025 | finance.yahoo.comSpectral AI, Inc. (MDAI) Q1 2025 Earnings Call TranscriptMay 13, 2025 | seekingalpha.comSpectral AI Announces 2025 First Quarter Financial ResultsMay 13, 2025 | globenewswire.comWhat's Next: Spectral AI's Earnings PreviewMay 12, 2025 | benzinga.comBurn clinicians present positive findings of the DeepView® System’s accuracy at the American Burn Association annual meetingApril 30, 2025 | finance.yahoo.comBurn clinicians present positive findings of the DeepView® System's accuracy at the American Burn Association annual meetingApril 30, 2025 | globenewswire.comSpectral AI files to sell 2.84M shares of common stock for holdersApril 26, 2025 | markets.businessinsider.comGlobal AI Diagnostics Market to Reach $8.54 Billion By 2033 as Industry Sees Increasing R&D and Strategic CollaborationsApril 16, 2025 | markets.businessinsider.comSpectral AI (MDAI) Secures $17.7 Million to Launch Burn Wound AI SystemMarch 31, 2025 | msn.comSpectral AI Inc. (MDAI) Poised for FDA Approval with Revolutionary DeepView SystemMarch 30, 2025 | msn.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeLYRA, CLGN, MDAI, and COCH Company DescriptionsCollPlant Biotechnologies NASDAQ:CLGN$1.38 -0.04 (-2.54%) Closing price 07/3/2025 12:48 PM EasternExtended Trading$1.41 +0.03 (+1.89%) As of 07/3/2025 04:39 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.CollPlant Biotechnologies Ltd., a regenerative and aesthetic medicine company, focuses on three-dimensional (3D) bioprinting of tissues and organs, and medical aesthetics in the United States, Canada, Israel, Europe, and internationally. Its products are based on recombinant type I human collagen that is produced with its proprietary plant based genetic engineering technology. The company's products include BioInks for 3D printing of tissues and organs; dermal filler and soft tissue fillers for treating wrinkles; 3D Bioprinted breast implants for regeneration of breast tissue; VergenixSTR, a soft tissue repair matrix intended for the treatment of tendinopathy; and VergenixFG, an advanced wound care product for the treatment of deep surgical incisions and wounds, including diabetic ulcers, venous and pressure ulcers, burns, bedsores, and other chronic wounds; as well as develops injectable breast implants and 3D bioprinted regenerative soft tissue matrix for use in breast reconstruction procedures. It has collaboration agreements with Advanced Regenerative Manufacturing Institute; RegenMed Development Organization; International Society for Biofabrication; AbbVie; and STEMCELL Technologies. The company was formerly known as CollPlant Holdings Ltd. and changed its name to CollPlant Biotechnologies Ltd. in June 2019. The company was founded in 2004 and is headquartered in Rehovot, Israel.Envoy Medical NASDAQ:COCH$1.58 +0.08 (+5.40%) As of 07/3/2025 01:00 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.Envoy Medical, Inc., a hearing health company, provides medical technologies for the hearing loss spectrum. Its products include personal sound amplification devices; hearing aids; Esteem fully implanted active middle ear implants; auditory osseointegrated implants; and Acclaim cochlear implants. The company was formerly known as Envoy Medical Corporation and changed its name to Envoy Medical, Inc. in September 2023. Envoy Medical, Inc. was founded in 1995 and is headquartered in White Bear Lake, Minnesota.Lyra Therapeutics NASDAQ:LYRA$9.02 -0.30 (-3.17%) Closing price 07/3/2025 03:45 PM EasternExtended Trading$9.12 +0.10 (+1.11%) As of 07/3/2025 04:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Lyra Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose, and throat diseases. It's XTreo technology platform is designed to deliver medicines directly to the affected tissue for sustained periods with a single administration. The company's product candidates include LYR-210, an anti-inflammatory implantable drug matrix for the treatment of chronic rhinosinusitis (CRS), which is in Phase III clinical trial; and LYR-220 for CRS patients with and without nasal polyps. It has a collaboration agreement with LianBio Inflammatory Limited to develop and commercialize LYR-210 in mainland China, Hong Kong, Taiwan, Macau, South Korea, Singapore, and Thailand. The company was formerly known as 480 Biomedical, Inc. and changed its name to Lyra Therapeutics, Inc. in July 2018. Lyra Therapeutics, Inc. was incorporated in 2005 and is headquartered in Watertown, Massachusetts.Spectral AI NASDAQ:MDAI$2.70 +0.18 (+6.92%) Closing price 07/3/2025 03:53 PM EasternExtended Trading$2.67 -0.04 (-1.29%) As of 07/3/2025 04:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Spectral AI, Inc., an artificial intelligence (AI) company, focuses on developing predictive medical diagnostics in the United States. The company develops medical diagnostics for faster and accurate treatment decisions in wound care with applications involving patients with burns and diabetic foot ulcers. Its products include DeepView System, a predictive analytics platform integrated with the predictive AI-Burn, which combines AI algorithms and multispectral imaging (MSI) imaging for an assessment of wound healing potential and offers clinicians an objective and immediate assessment of a wound's healing potential prior to treatment or other medical intervention; and DeepView SnapShot M, a handheld, portable, and wireless diagnostic tool, that provides a potential enhanced and expanded use for the government and emergency care, first responders, and potentially home health care professionals. The company is headquartered in Dallas, Texas. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas The Apple Comeback Will Be Better Than the Setback Micron’s Big Q3 Drives Applied Materials’ Bullish Outlook Why Occidental's Price Dip Signals a Buying Opportunity Qualcomm’s Hold Rating Misses Strong Growth Story Rigetti Computing: Cantor's Bullish Call May Be Just the Start Insider Selling at NVIDIA Could Turn Into an Opportunity Whiplash for Investors: AeroVironment's Confusing Stock Signals Rocket Lab: Latest Catalysts Bolster the Bull Case Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
